Suppr超能文献

微小RNA-3473b调节触发受体表达分子2/unc-51样激酶1的表达并在帕金森病炎症发病机制中抑制自噬。

MicroRNA-3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease.

作者信息

Lv Qiankun, Zhong Zhen, Hu Binbin, Yan Si, Yan Yufang, Zhang Junjun, Shi Ting, Jiang Lijuan, Li Wen, Huang Wei

机构信息

Department of Neurology, the Second Affiliated Hospital of Nanchang University, Nanchang, China.

出版信息

J Neurochem. 2021 May;157(3):599-610. doi: 10.1111/jnc.15299. Epub 2021 Feb 2.

Abstract

Parkinson disease (PD) is a neurodegenerative disease characterized by selective loss of dopaminergic (DA) neurons in the midbrain. The regulatory role of a variety of microRNAs in PD has been confirmed, and our study is the first to demonstrate that miR-3473b is involved in the regulation of PD. In vitro, an miR-3473b inhibitor can inhibit the secretion of inflammatory factors (TNF-α and IL-1β) in moues microglia cell line (BV2) cells induced by lipopolysaccharide (LPS) and promote autophagy in BV2 cells. In vivo, miR-3473b antagomir can inhibit the activation of substantia nigra pars compacta (SNpc) microglia of C57BL/6 mice induced by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and promote autophagy. Deletion of TREM2, one of the most highly expressed receptors in microglia, leads to the occurrence and development of PD. ULK1 is a component of the Atg1 complex. Deletion of ULK1 aggravates the pathological reaction of PD. TREM2 and ULK1 are predicted potential targets of miR-3473b by Targetscan. Then, the results of our experiments indicate that transfection with a miR-3473b mimic can inhibit the expression of TREM2 and ULK1. Data from a double luciferase experiment indicate that the 3'-UTR of TREM2, but not ULK1, is the direct target of miR-3473b. Then we aim to investigate the regulation of TREM2 and ULK1 in PD. We found that the expression of p-ULK1 was significantly increased via up-regulation of TREM2. The increased expression of p-ULK1 can promote autophagy and inhibit the expression of inflammatory factors. The regulation of ULK1 by miR-3473b may be accomplished indirectly through TREM2. Thus, miR-3473b may regulate the secretion of proinflammatory mediators by targeting TREM2/ULK1 expression to regulate the role of autophagy in the pathogenesis of inflammation in Parkinson's disease, suggesting that mir-3473b may be a potential therapeutic target to regulate the inflammatory response in PD.

摘要

帕金森病(PD)是一种神经退行性疾病,其特征是中脑多巴胺能(DA)神经元选择性丧失。多种微小RNA在帕金森病中的调节作用已得到证实,而我们的研究首次证明miR-3473b参与帕金森病的调节。在体外,miR-3473b抑制剂可抑制脂多糖(LPS)诱导的小鼠小胶质细胞系(BV2)细胞中炎性因子(TNF-α和IL-1β)的分泌,并促进BV2细胞中的自噬。在体内,miR-3473b拮抗剂可抑制1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的C57BL/6小鼠黑质致密部(SNpc)小胶质细胞的激活并促进自噬。小胶质细胞中表达最高的受体之一TREM2的缺失会导致帕金森病的发生和发展。ULK1是Atg1复合物的一个组成部分。ULK1的缺失会加重帕金森病的病理反应。通过Targetscan预测TREM2和ULK1是miR-3473b的潜在靶标。然后,我们的实验结果表明,转染miR-3473b模拟物可抑制TREM2和ULK1的表达。双荧光素酶实验数据表明,TREM2的3'-UTR而非ULK1的3'-UTR是miR-3473b的直接靶标。然后我们旨在研究TREM2和ULK1在帕金森病中的调节作用。我们发现,通过上调TREM2,p-ULK1的表达显著增加。p-ULK1表达的增加可促进自噬并抑制炎性因子的表达。miR-3473b对ULK1的调节可能是通过TREM2间接完成的。因此,miR-3473b可能通过靶向TREM2/ULK1的表达来调节促炎介质的分泌,从而调节自噬在帕金森病炎症发病机制中的作用,这表明miR-3473b可能是调节帕金森病炎症反应的潜在治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验